Document
IPR2018-00122, No. 2008 Exhibit - I MAK Our People (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00122, No. 2008 Exhibit - I MAK Our People (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00122, No. 2010 Exhibit - Hepatitis C Deserves the Attention (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00122, No. 2010 Exhibit - Hepatitis C Deserves the Attention (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00122, No. 2007 Exhibit - America¿¿¿s Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00122, No. 2007 Exhibit - America¿¿¿s Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00122, No. 2001 Exhibit - Nucleoside Analog Inhibitors of Hepatitis C Virus Replication (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00122, No. 2001 Exhibit - Nucleoside Analog Inhibitors of Hepatitis C Virus Replication (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00122, No. 2018 Exhibit - Synthesis and Pharmacokinetics of Valopicitabine NM283, an Efficient Prodrug of the Potent Anti HCV Agent 2¿¿¿ C Methylcytidine (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00122, No. 2018 Exhibit - Synthesis and Pharmacokinetics of Valopicitabine NM283, an Efficient Prodrug of the Potent Anti HCV Agent 2¿¿¿ C Methylcytidine (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00122, No. 2017 Exhibit - Pro Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Feb. 28, 2018...
Cite Document
IPR2018-00122, No. 2017 Exhibit - Pro Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00122, No. 2004 Exhibit - HARVONI¿¿ label (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00122, No. 2004 Exhibit - HARVONI¿¿ label (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00122, No. 2015 Exhibit - Discovery of a ¿¿ D 2¿¿¿ Deoxy 2¿¿¿ ¿¿ Cmethyluridine Nucleotide Prodrug PSI 7977 for the Treatment of Hepatitis C Virus (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00122, No. 2015 Exhibit - Discovery of a ¿¿ D 2¿¿¿ Deoxy 2¿¿¿ ¿¿ Cmethyluridine Nucleotide Prodrug PSI 7977 for the Treatment of Hepatitis C Virus (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00122, No. 2016 Exhibit - Review Article Investigational Agents for Chronic Hepatitis C (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00122, No. 2016 Exhibit - Review Article Investigational Agents for Chronic Hepatitis C (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00122, No. 2006 Exhibit - Clofarabine From Design to Approval (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00122, No. 2006 Exhibit - Clofarabine From Design to Approval (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00122, No. 2011 Exhibit - FDA Approves Pill to Treat Hepatitis C (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00122, No. 2011 Exhibit - FDA Approves Pill to Treat Hepatitis C (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00122, No. 2009 Exhibit - Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00122, No. 2009 Exhibit - Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00122, No. 2002 Exhibit - Curing Chronic Hepatitis C ¿¿¿ The Arc of a Medical Triumph (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00122, No. 2002 Exhibit - Curing Chronic Hepatitis C ¿¿¿ The Arc of a Medical Triumph (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00121, No. 2007-21 Exhibit - Americas Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00121, No. 2007-21 Exhibit - Americas Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices (P.T.A.B. Feb. 28, 2018)
+ More Snippets
Document
IPR2018-00121, No. 2003-17 Exhibit - FDA Approves Game Changer Hepatitis C Drug Sofosbuvir (P.T.A.B. Feb. 28, 2018)
Cite Document
IPR2018-00121, No. 2003-17 Exhibit - FDA Approves Game Changer Hepatitis C Drug Sofosbuvir (P.T.A.B. Feb. 28, 2018)
+ More Snippets